跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
GEMIBINE-200 POWDER FOR SOLUTION FOR INFUSION 200 MG VIAL - HSA Drug Approval Details
Approvals
/
HSA
/
GEMIBINE-200 POWDER FOR SOLUTION FOR INFUSION 200 MG VIAL
Approved
THERAPEUTIC
GEMIBINE-200 POWDER FOR SOLUTION FOR INFUSION 200 MG VIAL
INTAS PHARMACEUTICALS LTD.
🇸🇬 Health Sciences Authority
Approval Date
Sep 28, 2018
Approval ID
e974156ac25e297b
Company
INTAS PHARMACEUTICALS LTD.
Type
Therapeutic
Approval Details
Approval Id
e974156ac25e297b
Drug Name
GEMIBINE-200 POWDER FOR SOLUTION FOR INFUSION 200 MG VIAL
Product Name
GEMIBINE-200 POWDER FOR SOLUTION FOR INFUSION 200 MG VIAL
Approval Number
SIN15554P
Approval Date
2018-09-28
Registrant
ACCORD HEALTHCARE PRIVATE LIMITED
Licence Holder
ACCORD HEALTHCARE PRIVATE LIMITED
Drug Type
Therapeutic
Forensic Classification
Prescription Only
Dosage Form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route Of Administration
INTRAVENOUS
Atc Code
L01BC05
Atc Item Name
gemcitabine
Pharma Manufacturer Name
ACCORD HEALTHCARE PRIVATE LIMITED
Company Detail Path
/organization/accord-healthcare-private-limited
Active Ingredients
Gemcitabine HCl 221.71 mg eqv Gemcitabine
200 mg
GEMCITABINE HCL 221.71 MG EQV GEMCITABINE
200 MG
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Sep 28, 2018
Approval ID
e974156ac25e297b
Type
Therapeutic
Back to HSA Approvals
